Over the years, doctors and biologists have recorded information relating to genomics. Genomics is the study of genomes (all of an organism’s hereditary information); it’s a way to determine the genetic makeup of an organism. Now experts want to use this information to fight cancer. Imagine the possibilities of having customised cancer-killing methods.

According to Emily Singer, Third Rock Ventures is funding the development of drugs aimed at molecularly defined cancer. The organisation focuses on launching projects such as these in an effort to further the “exceptional life science companies”, which will hopefully make a difference in the lives of patients. It will be granting a substantial $40 million to Blueprint Medicine, which plans to use ample genomic information to develop new drugs targeting the mechanisms that drive the various streams of the disease.